Rifaximin Improves Cognitive Performance and Reduces Cirrhosis‐Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled Trial

Rifaximin Improves Cognitive Performance and Reduces Cirrhosis‐Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled Trial | ReachRx